CFMS - Conformis taps Asia-Pacific market via distribution agreement with XR Medical Group

Conformis (CFMS) +1.7% premarket, inks an agreement to enter the Asia-Pacific market through an exclusive distribution relationship with XR Medical Group (Hong Kong). As per the distribution agreement, XR Medical will have exclusive rights for the sale, marketing, and distribution of Conformis’ patient-specific iTotal CR & PS total knee replacement systems, iTotal CR & PS patella devices, and iUni and iDuo partial knee replacement systems. On behalf of Conformis, XR Medical’s sales team will provide sales and support exclusively to top-tier facilities in Hainan’s Boao Lecheng International Medical Tourism Pilot Zone, located on Hainan, a large island off China’s southern coast. Mark Augusti, President and CEO of Conformis said “What is particularly attractive about XR Medical is its strong performance in the Pilot Zone. We believe that starting in the Pilot Zone positions us well and we anticipate that this relationship will serve as a model for future expansion opportunities in mainland China.” The global market for knee

For further details see:

Conformis taps Asia-Pacific market via distribution agreement with XR Medical Group